Author/Authors :
Hartimath, S. V Agency for Science Technology and Research (A∗STAR) - Biopolis Way - Helios - Singapore, Singapore , Boominathan, R Agency for Science Technology and Research (A∗STAR) - Biopolis Way - Helios - Singapore, Singapore , Soh, V Agency for Science Technology and Research (A∗STAR) - Biopolis Way - Helios - Singapore, Singapore , Cheng, P Agency for Science Technology and Research (A∗STAR) - Biopolis Way - Helios - Singapore, Singapore , Deng, X Agency for Science Technology and Research (A∗STAR) - Biopolis Way - Helios - Singapore, Singapore , Chong, Y. C Agency for Science Technology and Research (A∗STAR) - Biopolis Way - Helios - Singapore, Singapore , Yong, F. F Agency for Science Technology and Research (A∗STAR) - Biopolis Way - Helios - Singapore, Singapore , Tan, P. W Agency for Science Technology and Research (A∗STAR) - Biopolis Way - Helios - Singapore, Singapore , Han, W Agency for Science Technology and Research (A∗STAR) - Biopolis Way - Helios - Singapore, Singapore , Robins, E. G Agency for Science Technology and Research (A∗STAR) - Biopolis Way - Helios - Singapore, Singapore , Goggi, J. L Agency for Science Technology and Research (A∗STAR) - Biopolis Way - Helios - Singapore, Singapore
Abstract :
Liver fibrosis is the hallmark of chronic nonalcoholic steatohepatitis (NASH) and is characterised by the excessive
deposition of extracellular matrix proteins. Early detection and accurate staging of liver fibrosis is critically important for patient
management. One of the earliest pathological markers in NASH is the activation of hepatic stellate cells (HSCs) which may be
exploited as a marker of fibrogenesis. Activated HSCs secreting factors such as integrin αvβ3 propagate fibrosis. The purpose of the
current study was to assess the utility of the integrin αvβ3 imaging agent [18F]FtRGD for the early detection of fibrosis in a dietinduced model of NASH longitudinally using PET imaging. Procedures. Mice were fed with either standard chow diet (SD), highfat diet (HFD), or a choline-deficient, L-amino acid-defined high-fat fibrogenic diet (CDAHFD) to mimic the clinical pathology of
liver disease and followed longitudinally for 10 weeks to assess the development of liver fibrosis using [18F]FtRGD positron
emission tomography (PET) imaging. Standard blood biochemistry, histological measures, and qPCR were used to quantify
integrin αvβ3, smooth muscle actin, and collagen types 1 and 6 to assess the extent of NASH pathology and accurately stage liver
fibrosis. Results. the CDAHFD fibrogenic diet predictably developed hepatic inflammation and steatosis over the 10 weeks studied
with little NASH pathology detected in high fat diet-treated animals. Stage 1 fibrosis was detected early by histology at day 21 and
progressed to stage 2 by day 35 and stage 3 by day 56 in mice fed with CDAHFD diet only. Noninvasive imaging with [18F]FtRGD
correlated well with integrin αvβ3 and was able to distinguish early mild stage 2 fibrosis in CDAHFD animals compared with
standard chow diet-fed animals at day 35. When compared with high fat diet-fed animals, [18F]FtRGD was only able to distinguish
later moderate stage 2 fibrosis in CDAHFD animals at day 49. Conclusions. the diet-induced progression of liver fibrosis was
confirmed using histology and correlated well with the mRNA of integrin αvβ3 and extracellular matrix protein expression. [18F]
FtRGD showed very good correlation between liver uptake and integrin αvβ3 expression and similar detection sensitivity to the
current clinical gold standard modalities for staging of liver fibrosis.